ASC nanobodies to counteract the consequences of inflammasome activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ASC nanobodies to counteract the consequences of inflammasome activation

Published:2022-05-16 Issue:6 Volume:14 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Adriouch Sahil¹^ORCID,Pelegrin Pablo²^ORCID

Affiliation:

1. UNIROUEN INSERM U1234 (PANTHER) Normandie University Rouen France

2. Biomedical Research Institute of Murcia (IMIB) University of Murcia Murcia Spain

Funder

Ministerio de Ciencia e Innovación

Fundación Séneca

Instituto de Salud Carlos III

Horizon 2020 Framework Programme

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202216087

Reference10 articles.

1. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response

2. Nanobodies dismantle post‐pyroptotic ASC specks and counteract inflammation in vivo

3. The gasdermins, a protein family executing cell death and inflammation

4. NLRP3 and pyroptosis blockers for treating inflammatory diseases

5. The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Targets in Innate Immunity to Tackle Alzheimer’s Disease;Cells;2024-08-26

2. NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies;Frontiers in Pharmacology;2024-07-31

3. Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives;Progress in Retinal and Eye Research;2024-07

4. Role of NLRP3 Inflammasome in Stroke Pathobiology: Current Therapeutic Avenues and Future Perspective;ACS Chemical Neuroscience;2023-12-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3